A new study entitled “Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study” published in October issue of BMC Pulmonary Medicine suggests that self-reported exercise improves nutritional and pulmonary outcomes in adults with cystic fibrosis. Cystic Fibrosis is a life-threatening disease, characterized…
News
App Developer Brian King’s “My Fight Against Cystic Fibrosis” is a Cystic Fibrosis app that is 100 percent designed, developed, and programmed by a CFer. King says the app’s mission is to provide the CF community with a useful tool and resource to help fight Cystic Fibrosis, in the hope…
Enterovirus D68, a non-polio enterovirus that causes mild to severe respiratory illness and can be spread through coughs, sneezes, or touch, has become a contagious problem in the United States. As a result, physicians are paying special attention to patients who already suffer from respiratory diseases or severe disease, such as cystic…
Synedgen, Inc. will present recent study results on the successful application of the company’s novel polymer PAAG for treating Cystic Fibrosis. The data is compiled in two posters entitled “PAAG decreases viscosity and Improves Transportability of Cystic Fibrosis Mucus In Situ” and “Novel Biopolymer Mucolytic PAAG Prevents and Treats Biofilms…
The Great Strides event, a fundraiser associated with the Cystic Fibrosis Foundation, has become the largest national fundraiser advocating for cystic fibrosis (CF), held through monthly initiatives and with the support of families, donors, and friends. This month, those honored by the event are Jen and Justin Grady,…
More and more people are turning to daring, extraordinary feats to call much-needed public attention to orphan diseases such as cystic fibrosis (CF), a debilitating and life-threatening hereditary condition that affects about 70,000 individuals throughout the world. A pair of brothers have recently committed themselves…
E. coli fluorescence Undergraduate students from the University of Dundee in Scotland are working on harnessing the power of laboratory-cultured, non-pathogenic E. coli to help cystic fibrosis patients fend off other harmful bacteria that could infect the lungs. Respiratory infections pose a serious threat to…
Data supporting a promising, new treatment for Cystic Fibrosis (CF) developed by Verona Pharma will be presented for the first time at the 28th Annual North American Cystic Fibrosis Conference (NACFC) in Atlanta, Georgia on October 9-11, 2014. Verona Pharma’s key molecule, RPL554, is currently being evaluated in a…
Dr. Stuart Elborn When it comes to formulating new and improved antibacterial treatments, scientists are in a race against the time it takes for today’s bacteria to mutate into more harmful, resistant strains. Even with today’s technology and advanced research practices, emerging pharmaceutical…
Young adults and children with cystic fibrosis in the United States have better lung function than those who live in the United Kingdom, despite the fact that both countries have well-developed healthcare systems. Differences in lung function may be a result of differences in healthcare structure, according to the…
Your CF Community
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.